TriSalus Life Sciences director Mats Wahlstrom reports $112,000 common share acquisition
TLSI•Director Mats Wahlstrom bought 50,000 TriSalus Life Sciences shares at $2.24 each, raising his direct holdings to 197,555 shares.
1. Share acquisition
Wahlstrom bought 50,000 shares of common stock at $2.24 each. His direct holdings rose to 197,555 shares; indirect holdings included 1,444,447 shares through Leonard Capital and 1,370,028 through HW Investment Partners.




